At the time of writing, AVITA Medical Inc [RCEL] stock is trading at $3.9, up 12.72%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RCEL shares have gain 14.71% over the last week, with a monthly amount glided 17.12%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
AVITA Medical Inc [NASDAQ: RCEL] stock has seen the most recent analyst activity on November 20, 2025, when BTIG Research upgraded its rating to a Neutral. Previously, BTIG Research downgraded its rating to Sell on August 08, 2025, and kept the price target unchanged to $3. On December 24, 2024, D. Boral Capital initiated with a Buy rating and assigned a price target of $25 on the stock. BTIG Research downgraded its rating to a Neutral. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $23 as its price target on June 27, 2023. Piper Sandler started tracking with a Overweight rating for this stock on March 02, 2021, and assigned it a price target of $27. In a note dated August 27, 2020, BofA Securities initiated an Buy rating and provided a target price of $42 on this stock.
For the past year, the stock price of AVITA Medical Inc fluctuated between $3.22 and $11.25. Currently, Wall Street analysts expect the stock to reach $3.5 within the next 12 months. AVITA Medical Inc [NASDAQ: RCEL] shares were valued at $3.9 at the most recent close of the market. An investor can expect a potential drop of -10.26% based on the average RCEL price forecast.
Analyzing the RCEL fundamentals
According to AVITA Medical Inc [NASDAQ:RCEL], the company’s sales were 72.40M for trailing twelve months, which represents an -12.71% plunge. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -0.58%, Pretax Profit Margin comes in at -0.67%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.76, Equity is 9.89 and Total Capital is -22.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that AVITA Medical Inc [NASDAQ:RCEL] has a current ratio of 0.67. Also, the Quick Ratio is 0.55, while the Cash Ratio stands at 0.25. Considering the valuation of this stock, the price to sales ratio is 1.34.
Transactions by insiders
Recent insider trading involved McNamara Robert, Director, that happened on Aug 28 ’25 when 10000.0 shares were purchased. CFO, O’Toole David D completed a deal on Aug 26 ’25 to buy 2000.0 shares. Meanwhile, Director McNamara Robert bought 10000.0 shares on Aug 19 ’25.
